Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A K Robison

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Coronary thrombolysis with facilitated absorption of intramuscularly injected tissue-type plasminogen activatorB E Sobel, L E Fields, A K Robison, et al.
Circulation|June 1, 1986
Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulationA J Tiefenbrunn, R A Graor, A K Robison, et al.
Circulation|December 1, 1985
Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activatorK A Fox, A K Robison, R M Knabb, et al.
The Journal of Clinical Investigation|September 1, 1978
Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardiumB E Sobel, P B Corr, A K Robison, et al.
Circulation|June 1, 1987
Intramuscular administration of human tissue-type plasminogen activator in rabbits and dogs and its implications for coronary thrombolysisB E Sobel, J E Saffitz, L E Fields, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1985
Coronary thrombolysis with facilitated absorption of intramuscularly injected tissue-type plasminogen activatorB E Sobel, L E Fields, A K Robison, et al.
Circulation|June 1, 1986
Pharmacodynamics of tissue-type plasminogen activator characterized by computer-assisted simulationA J Tiefenbrunn, R A Graor, A K Robison, et al.
Circulation|December 1, 1985
Prevention of coronary thrombosis with subthrombolytic doses of tissue-type plasminogen activatorK A Fox, A K Robison, R M Knabb, et al.
The Journal of Clinical Investigation|September 1, 1978
Accumulation of lysophosphoglycerides with arrhythmogenic properties in ischemic myocardiumB E Sobel, P B Corr, A K Robison, et al.
Circulation|June 1, 1987
Intramuscular administration of human tissue-type plasminogen activator in rabbits and dogs and its implications for coronary thrombolysisB E Sobel, J E Saffitz, L E Fields, et al.
Pageof 2